Specialty Clinics Overview
Obesity & Metabolic‑Health Clinic
Why act now?
Scope of the problem: More than 2 in 5 U.S. adults (42 %) live with obesity, and the national rate has hovered at approximately 40 % since 2021–2023. In 23 states, at least one‑third of adults meet clinical obesity criteria.
Trajectory: Severe obesity (BMI ≥ 40) continues to rise, now affecting almost 1 in 10 adults.
Body System
Conditions with Increased Risk
Cardiovascular
Hypertension, coronary heart disease, stroke, atrial fibrillation
Metabolic
Type 2 diabetes, dyslipidemia, insulin resistance, NAFLD
Cancer
Breast, colorectal, endometrial, kidney, pancreatic & more
Respiratory / Sleep
Obstructive sleep apnea, obesity hypoventilation
Musculoskeletal
Osteoarthritis, chronic back and joint pain
Reproductive
PCOS, infertility, pregnancy complications
Mental Health
Clinical depression and anxiety
Our comprehensive program:
- Whole‑person assessment: Baseline labs, body‑composition analysis, cardiometabolic and sleep screening.
- Lifestyle‑medicine core: One‑on‑one and group coaching in nutrition, physical activity, behavior change and stress resilience.
- Evidence‑based therapeutics: GLP‑1 receptor agonists & other anti‑obesity medications; endoscopic sleeve gastroplasty & bariatric surgery pathways for appropriate candidates.
- Integrated mental‑health support: On‑site psychologists to address binge‑eating, depression or anxiety that often accompany weight challenges.
- Digital follow‑through: App‑based food logging, remote vitals, tele‑check‑ins and peer support forums.
What to expect: First visit (60 min) → personalized care map → monthly multidisciplinary huddle. Measured outcomes include ≥ 5 % weight‑loss rate, A1c and BP improvement, sleep‑apnea symptom scores and quality‑of‑life metrics.
Diabetes & Cardiometabolic Clinic
Why it matters?
Scope: About 38 million U.S. adults (14.7 %) live with diabetes—and another 97.6 million (38 %) have pre‑diabetes. That is one in three adults already on the path toward the disease.
Trend: CDC data show prevalence has risen from 9.7 % in 2000 to over 14 % today—roughly 1 in 6 adults.
Preventable burden: More than 100,000 limb amputations every year are linked to poorly controlled diabetes.
Body System
Conditions with Increased Risk
Macro‑vascular
Heart attack, stroke (2× risk)
Micro‑vascular
Retinopathy/blindness (up to 90 % preventable), nephropathy → CKD (1 in 3), neuropathy & foot ulcers → amputations
Metabolic/acute
DKA, HHS, severe hypoglycemia
Mental health
Depression, diabetes distress
Our comprehensive program:
- Integrated endocrinology, diabetes educators, clinical pharmacists and behavioral coaches.
- Diagnostics: Same‑day A1C, eGFR, retinal imaging, foot Doppler, continuous‑glucose‑monitor uploads.
- Therapeutics: Metformin‑first pathway; SGLT2‑i and GLP‑1 RA escalation; in‑house CGM and insulin‑start classes; cardioprotective lipid/BP management.
- Lifestyle engine: Plant‑forward meal planning, resistance‑plus‑interval training, sleep & stress modules.
- Digital follow‑through: 24/7 chat, automated hypo alerts, peer support forums.
Outcome metrics we track – ≥ 1 % A1C reduction, ≥ 30 mg/dL LDL drop, foot‑ulcer‑free survival, vision‑saving exam compliance.
Hypertension & Vascular‑Risk Clinic
Why act now?
Prevalence: 47.7 % of U.S. adults—nearly 1 in 2—have hypertension; only 20.7 % have it controlled below 130/80 mm Hg.
Mortality: High blood pressure contributed to approximately 664,000 U.S. deaths in 2023 alone.
Untreated high BP dramatically raises the risk for:?
- Heart disease & heart failure
- Ischemic & hemorrhagic stroke
- Chronic kidney disease & ESRD
- Aortic aneurysm & PAD
- Cognitive decline / dementia
- Hypertensive retinopathy & vision loss
Our evidence‑based pathway:
- Baseline work‑up: 24‑hour ambulatory BP monitoring, renal panel, lipid profile, sleep‑apnea screen.
- Lifestyle first: DASH‑plus‑Mediterranean coaching, sodium & alcohol audit, resistance‑training prescription.
- Pharmacology tiers: ACE‑I/ARB → CCB/thiazide → mineralocorticoid antagonist, with rapid‑cycle titration every 4 weeks.
- Tech‑enabled adherence: Connected home cuffs feed our EMR dashboards; algorithmic alerts prompt medication adjustments.
- Team‑based care: Cardiology, nephrology, pharmacist‑run titration clinic, behavioral health for stress‑driven spikes.
Clinic goals – ≥ 70 % of patients <130/80 mm Hg within 6 months; ≥ 10‑point ASCVD‑risk reduction at 1 year.
Anxiety & Stress‑Resilience Clinic
Why prioritise anxiety care?
Prevalence: 19 % of adults have been told they have an anxiety disorder, and 13 % report persistent worry or nervousness in 2023 surveys.
Rising distress: An APA poll found 43 % of adults felt more anxious in 2024 than the year before.
Whole‑body impact: Meta‑analyses link clinical anxiety to a 40 % higher risk of cardiovascular death, stroke and heart failure; also to GI disorders, migraines and chronic insomnia.
Body System
Conditions with Increased Risk
Brief CBT / IPT (6‑10 sessions)
GAD‑7‑tracked progress; option for virtual drop‑ins
Exposure‑based & ERP programs
For social anxiety, phobias, OCD spectrum
Mind‑body groups
SSRIs/SNRIs, buspirone; short‑course benzodiazepines with taper plan
Augmented options
Ketamine‑assisted psychotherapy & rTMS for refractory cases (psychiatrist‑led)
Integrated supports – On‑site sleep‑medicine consults, cardiology screening for anxious‑tachycardia, registered dietitian for caffeine/alcohol triggers, and 24/7 crisis‑text integration.
Success metrics – ≥ 50 % GAD‑7 reduction, PSQI sleep‑score improvement, return‑to‑work rates.
Depression & Mood‑Disorders Clinic
Why prioritise mental health?
Current prevalence: Nearly 1 in 5 U.S. adults (17.8 %) report current depression and 29 % have been diagnosed at some point; rates have climbed 60 % in the past decade.
Two‑week snapshot: In 2021‑2023, 13.1 % of people aged 12+ experienced depressive symptoms in the past fortnight.
Whole‑body impact: Untreated depression heightens risk for heart disease, stroke, diabetes, chronic pain, osteoporosis and Alzheimer’s disease.
Service Level
Brief Psychotherapy Packages (6‑12 sessions)
Brief CBT / IPT (6‑10 sessions)
Cognitive‑Behavioral Therapy (CBT) or Interpersonal Therapy (IPT) delivered in person or via secure telehealth.
Skills‑Focused Group Programs
Skills‑Focused Group Programs
Comprehensive Outpatient
Combined medication management (SSRIs, SNRIs, atypical antidepressants) plus weekly individual or group therapy and lifestyle coaching.
Family & Couples Support
Sessions to strengthen communication, reduce relapse triggers and improve treatment adherence.
Tele‑Mental‑Health Hub
Evening & weekend virtual visits, app‑based mood tracking, crisis text line integration.
Integrated care team: Board‑certified psychiatrists, licensed therapists, social workers, primary‑care liaisons and peer specialists coordinate seamlessly through a unified electronic record.
Measured outcomes: PHQ‑9 reduction ≥ 50 %, improved work‑function, reduced cardiac‑risk profile in comorbid patients.
